Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma.

Nadia NinosuSusanne MelchersMax KappensteinNina BookenInga HansenMaël BlanchardEmmanuella GuenovaChalid AssafSergij GoerdtJan P Nicolay

Published in: Cancers (2023)

Our study presents the combination of mogamulizumab and ECP as an effective therapy in the blood and skin in CTCL with good tolerability, similar to mogamulizumab monotherapy.

Keyphrases

open label
clinical trial
mesenchymal stem cells
cell therapy
study protocol
smoking cessation